Editor's Choice Bacteria in cancer unmasked: a closer look at our microscopic co-inhabitants April 17, 2024 Researchers at the Netherlands Cancer Institute have compiled a detailed catalogue of bacteria living in…
Editor's Choice ANZUP’s ENZA-p combination breakthrough for patients with metastatic castration-resistant prostate cancer April 17, 2024 In a significant stride forward in treatment options for metastatic castration-resistant prostate cancer (mCRPC), a…
Editor's Choice Ask Chat GPT about your radiation oncology treatment April 6, 2024 Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be…
Editor's Choice New AI model detects 90% of lymphatic cancer cases April 4, 2024 Medical image analysis using AI has developed rapidly in recent years. Now, one of the…
Editor's Choice World-class centre tackles sex and gender inequities in health and medicine April 4, 2024 A new national research, policy and education centre to improve health outcomes for all Australians…
Editor's Choice Association between historical housing discrimination and shortfalls in colon cancer treatment April 3, 2024 A nationwide study of 196 cities in the United States, shows that housing discrimination from…
Editor's Choice Coffee reduces mortality in people with intestinal cancer March 30, 2024 Recent research published in the International Journal of Cancer indicates that individuals who have previously…
Digital Resources & Fundraising Ovarian Cancer Research Foundation announces $2.4 million in new funding March 22, 2024 Today, three ovarian cancer research institutions have received significant funding from the Ovarian Cancer Research…
COVID-19 Pandemic COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed March 21, 2024 Prostate cancer diagnoses in 20,000 men could have been missed due to the COVID-19 pandemic,…
Editor's Choice Bladder cancer trial SUBDUE-1 shows promising results using a sub-urothelial durvalumab injection March 19, 2024 The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) SUBDUE-1 trial, featured…